報價延遲最少15分鐘:2025/05/31 11:56 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.97 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.46/-0.46
|
|
企業價值
265.62M
|
| 資產負債 |
|
每股賬面淨值
0.67
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 11:56 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel. |